Next-Generation Sequencing Reveals the Role of Epigallocatechin-3-Gallate in Regulating Putative Novel and Known microRNAs Which Target the MAPK Pathway in Non-Small-Cell Lung Cancer A549 Cells

Lung cancer constitutes 85% of non-small cell lung cancer diagnosed cases. MicroRNAs are novel biomarkers that are capable of modulating multiple oncogenic pathways. Epigallocatechin-3-gallate (EGCG) is a potent chemopreventive and chemotherapeutic agent for cancer. We aimed to identify important kn...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhardwaj, Vaishali, Mandal, Abul Kalam Azad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359307/
https://www.ncbi.nlm.nih.gov/pubmed/30669618
http://dx.doi.org/10.3390/molecules24020368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359307/
https://www.ncbi.nlm.nih.gov/pubmed/30669618
http://dx.doi.org/10.3390/molecules24020368

Ejemplares similares